arrow_back Back to App

Detecting Illicit Drugs: New Methods and Research for Public Safety

This act aims to enhance the government's ability to detect and analyze dangerous substances like xylazine and novel synthetic opioids. By improving identification methods, authorities can respond more quickly to these threats, thereby increasing public safety and more effectively combating drug-related issues, ultimately protecting citizens' health.
Key points
Support for scientific research into new methods for detecting and analyzing dangerous substances, including xylazine and synthetic opioids.
Development of technologies for faster drug and psychoactive substance detection, aiding quicker response from authorities.
Collaboration between government agencies, universities, and the private sector to improve drug detection capabilities.
A study will be conducted to assess the government's capacity to respond to threats from new psychoactive substances.
article Official text account_balance Process page
VOTING RESULTS
2023-05-11
100%
For 425
Against 0
Abstain 0
Full voting results open_in_new
Became Law
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_1734
Sponsor: Rep. Collins, Mike [R-GA-10]
Process start date: 2023-03-23
Voting date: 2023-05-11
Meeting no: 1
Voting no: 212
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

TRANQ Research Act of 2023

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_1734.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-03-23.

What are the main provisions?

Key points include:

  • Support for scientific research into new methods for detecting and analyzing dangerous substances, including xylazine and synthetic opioids.
  • Development of technologies for faster drug and psychoactive substance detection, aiding quicker response from authorities.
  • Collaboration between government agencies, universities, and the private sector to improve drug detection capabilities.
  • A study will be conducted to assess the government's capacity to respond to threats from new psychoactive substances.
What is the specific legal status?

The current status is Became Law.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Where is the official voting record?

The official roll call vote is recorded at: voting record

Who is the primary sponsor?

The primary sponsor is Rep. Collins, Mike [R-GA-10].

What is the latest detailed status?

The latest detailed status is: Became Public Law No: 118-23.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.

CATEGORIES

Health Security